葛兰素史克Glaxosmithkline plc (GSK) 2004年年度报告「LSE」.pdf

1、Do more,feel better,live longerNew challengesNew thinkingAnnual Report 2004GlaxoSmithKline plc is an English public limited company.It shares are listed on the London Stock Exchange and theNew York Stock Exchange.History and development of the companyGlaxoSmithKline plc,and its subsidiary and associ

2、atedundertakings,constitute a major global healthcare group engaged in the creation,discovery,development,manufacture and marketing of pharmaceutical and consumer health-related products.GlaxoSmithKline has its corporate head office in London.It also has operational headquarters in Philadelphia and

3、Research Triangle Park,USA,and operations in some 116 countries,with products sold in over 125 countries.The principal research and development(R&D)facilities are in the UK,the USA,Japan,Italy,Spain and Belgium.Products are currently manufactured in some 38 countries.The major markets for the Groups

4、 products are the USA,France,Japan,the UK,Italy,Germany and Spain.GlaxoSmithKline plc is a public limited company incorporated on 6th December 1999 under English law.On 27th December 2000 the company acquired Glaxo Wellcome plc and SmithKline Beecham plc,both English public limited companies,by way

5、of a scheme of arrangement for the merger of the two companies.Both Glaxo Wellcome and SmithKline Beecham were major global healthcare businesses.MissionOur global quest is to improve the quality of human life by enabling people to do more,feel better and live longer.Our SpiritWe undertake our quest

6、 with the enthusiasm of entrepreneurs,excited by the constant search for innovation.We valueperformance achieved with integrity.We will attain success as a world class global leader with each and everyone of our people contributing with passion and an unmatched sense of urgency.Strategic IntentWe wa